<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
LSX: The Network For Life Science Executives.png
LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.
Josh Price

Written By
Josh Price

M&A deals and the pharmaceutical sector: Are your IP ducks in a row?

IP, Regulation and Compliance M&A and Deal Making Expert Insight Pharma

23 October 2018
Josh Price Josh Price
October 23, 2018

M&A deals and the pharmaceutical sector: Are your ...

2018 has so far been a productive year for M&A deals in the pharmaceutical ...

Read More
Louise Fordham Louise Fordham
October 23, 2018

Artios Pharma’s £65m Series B to spur development ...

Key findings:

Read More
LSX LSX
October 11, 2018

Have your say on life sciences investment trends

LSX, formerly Biotech and Money, is conducting the 3rd Investor Perception ...

Read More
Louise Fordham Louise Fordham
October 09, 2018

Dyadic International: Working to change the game i...

Key learnings:

Read More
Mark Corbett Mark Corbett
October 04, 2018

What life sciences companies need to know about pr...

Pre-approval access is evolving at a rapid pace. Mark Corbett (pictured), E...

Read More
Louise Fordham Louise Fordham
October 03, 2018

Forendo Pharma receives €4m boost to progress wome...

Key learnings: Vesalius BioCapital III Partners invested €4 million in Finl...

Read More
Louise Fordham Louise Fordham
October 02, 2018

Evox Therapeutics raises £35.5m Series B to advanc...

Key learnings: UK biotech Evox Therapeutics recently announced its £35.5 mi...

Read More
Finn Nikolajsen Finn Nikolajsen
October 02, 2018

Addressing the challenges of ownership structures ...

The development of new products in the life science industry is a very time...

Read More
Louise Fordham Louise Fordham
October 01, 2018

Exploring life sciences investment trends with Min...

Key learnings: Leading US life sciences law firm Mintz has been active in t...

Read More
Dr Stefan Fraenkel Dr Stefan Fraenkel
September 20, 2018

Commercialise and partner successfully in Europe a...

Understand how to commercialise via partnering in Europe and other markets ...

Read More
A. Sinclair Dunlop A. Sinclair Dunlop
September 17, 2018

Key challenges to scaling up early-stage investmen...

Access to venture capital and effective fundraising tactics are key to buil...

Read More
Dr Michael Hopkins Dr Michael Hopkins
September 17, 2018

Brexit: finite uncertainty

One might think that planning for uncertainty is something that biotech fir...

Read More

Add Your Response

ABOUT THE BLOG

The LSX Blog provides genuine thought leadership, exclusive executive insight and market intelligence on the life science and healthcare investment sector.

CATEGORIES

see all

Subscribe Email

UPCOMING CONFERENCE
LSX World Congress.png


5-6 February 2019 | St Paul's | London 

 

Strategy, Investment and Partnering for Life Science Executive Leaders

 

 
LEARN MORE
Popup Close

The 5th annual LSX World Congress is a high-calibre, senior executive, two-day conference and partnering event.
 
DOWNLOAD BROCHURE
ABOUT US

LSX (formerly Biotech and Money) - The network for life science executive leaders

Company Homepage
SITE MAP
HELP

© 2018 All Rights Reserved By LSX Ltd (formerly Biotech and Money Ltd)
Arrow Image.png